Boston Scientific Quick Ratio 2010-2024 | BSX
Boston Scientific Quick Ratio Historical Data | |||
---|---|---|---|
Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
2024-03-31 | $5.62B | $4.92B | 1.14 |
2023-12-31 | $4.03B | $4.93B | 0.82 |
2023-09-30 | $4.10B | $4.58B | 0.90 |
2023-06-30 | $3.64B | $4.56B | 0.80 |
2023-03-31 | $3.65B | $4.08B | 0.90 |
2022-12-31 | $3.89B | $3.80B | 1.02 |
2022-09-30 | $3.36B | $3.55B | 0.95 |
2022-06-30 | $3.33B | $3.88B | 0.86 |
2022-03-31 | $3.33B | $4.28B | 0.78 |
2021-12-31 | $4.71B | $4.27B | 1.10 |
2021-09-30 | $4.63B | $4.02B | 1.15 |
2021-06-30 | $5.33B | $4.07B | 1.31 |
2021-03-31 | $4.69B | $3.39B | 1.38 |
2020-12-31 | $5.34B | $3.68B | 1.45 |
2020-09-30 | $4.69B | $3.30B | 1.42 |
2020-06-30 | $4.29B | $3.11B | 1.38 |
2020-03-31 | $3.20B | $3.98B | 0.80 |
2019-12-31 | $3.12B | $4.87B | 0.64 |
2019-09-30 | $3.28B | $4.25B | 0.77 |
2019-06-30 | $5.03B | $4.85B | 1.04 |
2019-03-31 | $5.01B | $4.48B | 1.12 |
2018-12-31 | $2.84B | $5.26B | 0.54 |
2018-09-30 | $2.84B | $5.08B | 0.56 |
2018-06-30 | $2.84B | $4.75B | 0.60 |
2018-03-31 | $2.97B | $4.99B | 0.60 |
2017-12-31 | $2.74B | $5.65B | 0.49 |
2017-09-30 | $2.40B | $4.83B | 0.50 |
2017-06-30 | $2.20B | $4.30B | 0.51 |
2017-03-31 | $2.06B | $3.49B | 0.59 |
2016-12-31 | $2.28B | $3.59B | 0.64 |
2016-09-30 | $2.18B | $3.02B | 0.72 |
2016-06-30 | $2.35B | $3.18B | 0.74 |
2016-03-31 | $2.14B | $2.61B | 0.82 |
2015-12-31 | $2.46B | $2.43B | 1.01 |
2015-09-30 | $2.38B | $2.24B | 1.06 |
2015-06-30 | $2.81B | $1.94B | 1.45 |
2015-03-31 | $2.23B | $2.46B | 0.91 |
2014-12-31 | $2.66B | $2.85B | 0.94 |
2014-09-30 | $2.19B | $1.82B | 1.20 |
2014-06-30 | $2.27B | $1.77B | 1.28 |
2014-03-31 | $2.01B | $1.72B | 1.17 |
2013-12-31 | $2.11B | $1.82B | 1.16 |
2013-09-30 | $2.63B | $1.90B | 1.38 |
2013-06-30 | $2.66B | $2.48B | 1.07 |
2013-03-31 | $2.25B | $1.64B | 1.38 |
2012-12-31 | $2.14B | $1.77B | 1.21 |
2012-09-30 | $2.26B | $1.82B | 1.25 |
2012-06-30 | $2.21B | $1.79B | 1.23 |
2012-03-31 | $2.20B | $1.67B | 1.32 |
2011-12-31 | $2.17B | $1.81B | 1.20 |
2011-09-30 | $2.24B | $1.89B | 1.19 |
2011-06-30 | $2.22B | $1.89B | 1.17 |
2011-03-31 | $2.67B | $2.04B | 1.31 |
2010-12-31 | $2.72B | $2.61B | 1.04 |
2010-09-30 | $2.63B | $2.96B | 0.89 |
2010-06-30 | $3.10B | $3.72B | 0.83 |
2010-03-31 | $2.84B | $2.91B | 0.98 |
2009-12-31 | $3.71B | $3.02B | 1.23 |
2009-09-30 | $4.02B | $3.18B | 1.27 |
2009-06-30 | $3.92B | $2.75B | 1.43 |
2009-03-31 | $3.72B | $2.43B | 1.53 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $112.541B | $14.240B |
Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $183.183B | 23.99 |
Stryker (SYK) | United States | $129.169B | 30.94 |
Medtronic (MDT) | Ireland | $103.915B | 15.56 |
EssilorLuxottica (ESLOY) | France | $102.324B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $40.451B | 0.00 |
Haleon (HLN) | United Kingdom | $39.452B | 28.80 |
ResMed (RMD) | United States | $26.766B | 25.13 |
Terumo (TRUMY) | Japan | $24.090B | 34.02 |
Koninklijke Philips (PHG) | Netherlands | $23.739B | 18.84 |
Zimmer Biomet Holdings (ZBH) | United States | $22.313B | 14.25 |
Baxter (BAX) | United States | $17.423B | 12.39 |
Insulet (PODD) | United States | $14.284B | 63.33 |
Demant (WILYY) | Denmark | $10.984B | 0.00 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.977B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.098B | 26.48 |
BellRing Brands (BRBR) | United States | $7.479B | 35.18 |
Lantheus Holdings (LNTH) | United States | $5.472B | 13.64 |
GN Store Nord (GNNDY) | Denmark | $4.529B | 25.43 |
Haemonetics (HAE) | United States | $4.368B | 21.54 |
Neogen (NEOG) | United States | $3.591B | 34.54 |
Perrigo (PRGO) | Ireland | $3.561B | 10.79 |
Prestige Consumer Healthcare (PBH) | United States | $3.418B | 16.27 |
Envista Holdings (NVST) | United States | $2.910B | 12.01 |
TG Therapeutics (TGTX) | United States | $2.845B | 80.04 |
ICU Medical (ICUI) | United States | $2.837B | 25.04 |
Green Thumb Industries (GTBIF) | United States | $2.671B | 52.29 |
Agios Pharmaceuticals (AGIO) | United States | $2.568B | 0.00 |
QuidelOrtho (QDEL) | United States | $2.271B | 12.61 |
LeMaitre Vascular (LMAT) | United States | $1.800B | 52.76 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.781B | 0.00 |
Warby Parker (WRBY) | United States | $1.539B | 0.00 |
InMode (INMD) | Israel | $1.514B | 8.05 |
AdaptHealth (AHCO) | United States | $1.353B | 10.06 |
Verano Holdings (VRNOF) | United States | $1.275B | 0.00 |
Owens & Minor (OMI) | United States | $1.237B | 10.78 |
AtriCure (ATRC) | United States | $1.048B | 0.00 |
National Vision Holdings (EYE) | United States | $1.015B | 32.30 |
BioLife Solutions (BLFS) | United States | $0.991B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.820B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.705B | 15.01 |
Evolus (EOLS) | United States | $0.658B | 0.00 |
PetIQ (PETQ) | United States | $0.647B | 20.92 |
Surmodics (SRDX) | United States | $0.598B | 37.46 |
VAREX IMAGING (VREX) | United States | $0.589B | 13.86 |
Valneva SE (VALN) | France | $0.544B | 0.00 |
Canopy Growth (CGC) | Canada | $0.525B | 0.00 |
Quanterix (QTRX) | United States | $0.490B | 0.00 |
Jin Medical (ZJYL) | China | $0.457B | 0.00 |
Biote (BTMD) | United States | $0.456B | 10.50 |
TerrAscend (TSNDF) | Canada | $0.434B | 0.00 |
ZimVie (ZIMV) | United States | $0.404B | 34.40 |
OraSure Technologies (OSUR) | United States | $0.317B | 10.19 |
Cerus (CERS) | United States | $0.312B | 0.00 |
MacroGenics (MGNX) | United States | $0.282B | 0.00 |
Zynex (ZYXI) | United States | $0.278B | 38.00 |
Aurora Cannabis (ACB) | Canada | $0.278B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.254B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.250B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.248B | 24.61 |
Omeros (OMER) | United States | $0.237B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.235B | 14.79 |
High Tide (HITI) | Canada | $0.183B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.163B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.158B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.153B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.152B | 73.00 |
FitLife Brands (FTLF) | United States | $0.151B | 21.43 |
Quipt Home Medical (QIPT) | United States | $0.132B | 0.00 |
Veru (VERU) | United States | $0.125B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
Brainsway (BWAY) | Israel | $0.107B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.103B | 0.00 |
Fonar (FONR) | United States | $0.096B | 9.74 |
InterCure (INCR) | Israel | $0.094B | 15.92 |
Allurion Technologies (ALUR) | United States | $0.091B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
Chimerix (CMRX) | United States | $0.081B | 0.00 |
MariMed (MRMD) | United States | $0.073B | 0.00 |
Safety Shot (SHOT) | United States | $0.059B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.058B | 3.80 |
Bright Green (BGXX) | United States | $0.056B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.056B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.050B | 0.00 |
Apyx Medical (APYX) | United States | $0.047B | 0.00 |
United-Guardian (UG) | United States | $0.042B | 15.25 |
Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
ImmuCell (ICCC) | United States | $0.035B | 0.00 |
Modular Medical (MODD) | United States | $0.034B | 0.00 |
Exagen (XGN) | United States | $0.033B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.022B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.018B | 0.00 |
Agape ATP (ATPC) | $0.017B | 0.00 | |
GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
Flora Growth (FLGC) | United States | $0.012B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |